Intensive glycemic control linked to highest weight gains

Intensive glycemic control linked to highest weight gains
Weight gain is higher in patients with type 2 diabetes mellitus who receive more intensive glycemic control treatment and is associated with a reduction of A1C from baseline, according to research published online Feb. 14 in Diabetes Care.

(HealthDay)—Weight gain is higher in patients with type 2 diabetes mellitus (T2DM) who receive more intensive glycemic control treatment and is associated with a reduction of A1C from baseline, according to research published online Feb. 14 in Diabetes Care.

Vivian Fonseca, M.D., of Tulane University's Health Sciences Center in New Orleans, and colleagues studied the determinants of weight gain in 8,929 patients with T2DM from the Action to Control Cardiovascular Risk in Diabetes trial who either participated in standard (4,504) or intensive glycemic control treatment arms (4,425).

The researchers found that patients in the intensive glycemia arm gained an average of 2.7 kg more than those in the standard arm (3.0 versus 0.3 kg). Independent factors associated with weight gain over the two-year treatment duration included younger age, male sex, Asian race, no smoking history, high A1C, baseline of 25 to 35 kg/m², high , baseline insulin use, and baseline metformin use. Overall, medication use was associated with less than 15 percent of the variability in weight change.

"Following randomization, the intensive group participants with the greatest reduction in A1C gained the most weight," the authors write. "Insulin and TZD [thiazolidinedione] use was associated with the greatest weight gain. Nevertheless, appreciation of these characteristics may help develop strategies to prevent weight gain when initiating intensive glycemic control in the future."

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

T1DM insulin intensification patterns, outcomes studied

Jan 30, 2013

(HealthDay)—About half of youths with type 1 diabetes shift to a more intensive insulin regimen over time, which is associated with better glycemic control, according to research published in the January ...

Dapagliflozin aids glycemic control in type 2 diabetes

Mar 20, 2012

(HealthDay) -- For patients with inadequately controlled type 2 diabetes, treatment with dapagliflozin is associated with improved glycemic control, stabilized insulin dosing, and weight reductions, according ...

Pre-op factors predict post-gastric op glycemic response

Oct 08, 2012

(HealthDay)—The glycemic response to gastric bypass surgery can be predicted in Chinese patients with type 2 diabetes by three preoperative factors, according to a study published online Oct. 1 in Diabetes Ca ...

Recommended for you

User comments